Quality made in Germany
Your reliable partner laboratory
In ChemCon you will find an internationally operating partner for the synthesis and analysis of pharmaceutical ingredients (APIs, GMP) and fine chemicals.
You are spot-on, if you are looking for a chemical substance (organic, inorganic, polymeric) in small to medium quantities. Examples are active pharmaceutical ingredients (APIs) in preclinical and clinical studies or for commercial chemical and pharmaceutical application.
ChemCon’s analytics team takes care of your inquiries if you are looking for ICH-compliant quality control, GMP validation, release analysis, impurity determination, reference standards or answers to other analytical queries.
On top of our chemical services, you will also find selected products in ChemCon’s portfolio.
Quality assurance and regulatory consulting completes comprehensive GMP-compliant production and analysis, validation and documentation.
Small but important? Kilolab services availabe for commercial supply
Commercial contract manufacturing
We enable commercial routine production for an annual requirement of < 100 g to several 100 kg.
Your pharmaceutical ingredients are produced to GMP guidelines and your specifications for application in injectable, ophthalmic, oral, or topic formulations.
We also produce chemicals, starting materials, or reference standards upon inquiry. Our analytics team takes care of qualification and release for you.
Quality confirmed by FDA and German authorities
Audits and GMP inspections
Since founding in 1997, ChemCon has been audited over 150 times, to the full satisfaction of the customers. We are looking back onto a long list of successful GMP inspections, most recently 2018 by the FDA (US Food and Drug Administration) and by German authorities (Regierungspräsidium Tübingen, EU GMP)
News & Events
Biotech & Pharma Virtual Partnering Conference 2020
This year not in Osaka, but virtual and free of charge
Biotechgate Digital Partnering
Free digital Partnering from August 31 - September 03, 2020
ChinaBIO® Partnering Forum Digital
Access to innovation opens up new opportunities for us all
load more news